Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2021-12-20 to 2022-01-12
Current total value of award: $303.4
Description: 4555780301!ZOLADEX 3.6 MG IMPLANT SYRNS